Are you actually serious ? If/when we start a phase 2 for TBI etc, dosage rates and delivery methods below have been proven safe already. Do you expect we do another phase 1 that is 100% identical to the first phase 1 trial ?
The aim of this pilot study was to investigate whether ARG-007, delivered intravenously at
either a 100 nmol/kg or 300 nmol/kg dose, can improve motor and cognitive outcome with
an associated reduction in axonal injury and neuroinflammation at 3 days following a mildmoderate diffuse head injury in ferrets. The animals were randomly allocated via a random
number generator to sham (uninjured) (n = 9) or injury (n = 25), with injured ferrets
administered either vehicle (saline; n = 10), 100nmol/kg (0.3 mg/kg) R18D (n =8) or
300nmol/kg (0.9 mg/kg) R18D (n = 7).
I'm thinking you are trying to get some cheap shares with a bit of misinformation ... good luck
Are you actually serious ? If/when we start a phase 2 for TBI...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
83.3¢ |
Change
0.023(2.78%) |
Mkt cap ! $108.0M | |||
| Open | High | Low | Value | Volume |
| 82.5¢ | 86.5¢ | 81.0¢ | $189.7K | 225.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11621 | 82.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 84.5¢ | 15000 | 1 |
View Market Depth
| Last trade - 15.57pm 12/08/2024 (20 minute delay) ? |
| AGN (ASX) Chart |